Trexquant Investment LP Ironwood Pharmaceuticals Inc Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$5.58 - $8.61 $3.92 Million - $6.04 Million	701,941 Added 542.14%	831,416 $5.42 Million
Q1 2024 May 14, 2024	BUY	$8.32 - $15.45 $1.08 Million - $2 Million	129,475 New	129,475 $1.13 Million
Q2 2023 Aug 11, 2023	SELL	$10.1 - $11.6 $1.07 Million - $1.23 Million	-105,715 Reduced 47.26%	117,956 $1.26 Million
Q1 2023 May 15, 2023	BUY	$10.37 - $12.56 $487,234 - $590,131	46,985 Added 26.59%	223,671 $2.35 Million
Q4 2022 Feb 13, 2023	BUY	$9.9 - $12.43 $623,373 - $782,679	62,967 Added 55.37%	176,686 $2.19 Million
Q3 2022 Nov 14, 2022	BUY	$10.14 - $12.38 $668,824 - $816,572	65,959 Added 138.11%	113,719 $1.18 Million
Q2 2022 Aug 11, 2022	SELL	$11.05 - $12.72 $184,037 - $211,851	-16,655 Reduced 25.86%	47,760 $551,000
Q1 2022 May 13, 2022	BUY	$10.61 - $12.88 $683,443 - $829,665	64,415 New	64,415 $810,000
Q2 2021 Aug 12, 2021	SELL	$10.16 - $13.11 $535,787 - $691,355	-52,735 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$9.04 - $11.86 $476,724 - $625,437	52,735 New	52,735 $590,000
Q4 2020 Feb 11, 2021	SELL	$9.05 - $12.2 $334,379 - $450,765	-36,948 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$8.99 - $10.74 $273,484 - $326,721	-30,421 Reduced 45.16%	36,948 $332,000
Q2 2020 Aug 07, 2020	BUY	$9.14 - $11.97 $227,183 - $297,526	24,856 Added 58.47%	67,369 $695,000
Q1 2020 May 08, 2020	SELL	$8.58 - $14.01 $104,049 - $169,899	-12,127 Reduced 22.19%	42,513 $429,000
Q4 2019 Feb 12, 2020	BUY	$8.22 - $14.0 $449,140 - $764,960	54,640 New	54,640 $727,000
Q3 2019 Nov 08, 2019	SELL	$8.59 - $10.96 $205,962 - $262,787	-23,977 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$9.8 - $12.89 $234,974 - $309,063	23,977 New	23,977 $262,000
Q1 2019 May 13, 2019	SELL	$8.27 - $12.73 $256,709 - $395,151	-31,041 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$7.8 - $16.13 $160,149 - $331,181	20,532 Added 195.38%	31,041 $322,000
Q3 2018 Nov 09, 2018	SELL	$14.31 - $17.65 $512,326 - $631,905	-35,802 Reduced 77.31%	10,509 $194,000
Q2 2018 Aug 07, 2018	SELL	$11.83 - $16.2 $180,383 - $247,017	-15,248 Reduced 24.77%	46,311 $885,000
Q1 2018 May 03, 2018	BUY	$11.13 - $13.63 $685,151 - $839,049	61,559 New	61,559 $950,000

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

Black Rock Inc. New York, NY

22.9M
Shares

$80.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

22M
Shares

$77.8 Million
0.0% of portfolio
Sarissa Capital Management LP Greenwich, CT

16.4M
Shares

$57.9 Million
16.75% of portfolio
Pacer Advisors, Inc. Malvern, PA

11.3M
Shares

$39.8 Million
0.11% of portfolio
State Street Corp Boston, MA

9.92M
Shares

$35 Million
0.0% of portfolio

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account